Showing 19,661 - 19,680 results of 105,100 for search '(( 50 we decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.58s Refine Results
  1. 19661
  2. 19662
  3. 19663
  4. 19664

    CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants by Kalpana Dommaraju (650755)

    Published 2014
    “…The paucity of CD8 T cell responses identified following RV144 vaccination, with no evidence for V2 specificity, considered together both with the association of decreased infection risk in RV 144 participants with V-specific antibody responses and a V2 sieve effect, lead us to hypothesize that this sieve effect was not T cell specific. …”
  5. 19665
  6. 19666
  7. 19667
  8. 19668
  9. 19669
  10. 19670
  11. 19671
  12. 19672
  13. 19673

    Role of the ACB domain and linker region in NMT2 activity. by Eric Soupene (64584)

    Published 2020
    “…Human NMT2 enzyme was added at a concentration of 50nM in the presence of 5μM C<sub>14</sub>-CoA. …”
  14. 19674

    The direct and indirect effects of the pneumococcal conjugated vaccine on carriage rates in children aged younger than 5 years in Latin America and the Caribbean: a systematic revi... by Stefany Martins Silva (8046230)

    Published 2019
    “…All selected publications were observational studies and indicated a decrease in the carriage and vaccine types, and an increase in the circulation of non-vaccine serotypes, such as 6A, 19A, 35B, 21 and 38. …”
  15. 19675

    Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”
  16. 19676

    Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

    Published 2023
    “…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”
  17. 19677

    Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”
  18. 19678
  19. 19679
  20. 19680

    Physico-chemical characterization of PvTRAg33.5. by Hema Bora (141649)

    Published 2011
    “…<p>Far UV CD spectra at different pH (a), emission wavelength at maximum intensity after exciting it at 295 nm as a function of pH (b), fluorescence intensity (filled circle) and emission wavelength at maximum intensity (empty circle) (inset) of ANS-protein complex as a function of pH, after exciting it at 380 nm (c), fluorescence intensities and emission wavelength maxima (inset) after exciting at 295 nm as a function of increase in temperature (empty circle) and consecutive decrease in temperature (filled circle) at pH 7.0 (d), far UV CD spectra and fluorescence intensities (inset) in the absence and presence of different ammonium sulfate concentrations at pH 7.0 after excited at 295 nm (e), and far UV CD spectra and fluorescence intensities (inset) in the absence (N) and presence of different ethanol concentrations after exciting at 295 nm (f) of PvTRAg33.5.…”